McBride plc (LON:MCB – Get Free Report) insider Mark Strickland bought 9,500 shares of the business’s stock in a transaction that occurred on Friday, November 15th. The shares were acquired at an average cost of GBX 97 ($1.22) per share, for a total transaction of £9,215 ($11,613.11).
Mark Strickland also recently made the following trade(s):
- On Friday, September 20th, Mark Strickland sold 113,846 shares of McBride stock. The stock was sold at an average price of GBX 116 ($1.46), for a total value of £132,061.36 ($166,428.94).
McBride Price Performance
Shares of MCB opened at GBX 99.20 ($1.25) on Monday. The firm has a market capitalization of £172.14 million, a price-to-earnings ratio of 522.11, a PEG ratio of -0.36 and a beta of 1.17. The firm’s fifty day simple moving average is GBX 114.80 and its 200-day simple moving average is GBX 121.87. McBride plc has a twelve month low of GBX 48.70 ($0.61) and a twelve month high of GBX 145 ($1.83). The company has a current ratio of 0.92, a quick ratio of 0.54 and a debt-to-equity ratio of 222.08.
McBride Company Profile
McBride plc, together with its subsidiaries, manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Australia, rest of Europe, rest of Asia-Pacific, and internationally. The company operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.
Featured Articles
- Five stocks we like better than McBride
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- When to Sell a Stock for Profit or Loss
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Buy P&G Now, Before It Sets A New All-Time High
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for McBride Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McBride and related companies with MarketBeat.com's FREE daily email newsletter.